Publication | Closed Access

Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer’s disease in rats by targeting Keap1/Nrf2 and MAPK-38p/ERK signaling pathways

Neurodegenerative DiseasesAlzheimer's DiseaseActive FormMedicineNeuropharmacologyDegenerative PathologyNeuroprotectionNeurologyNeuroscienceNeurodegenerationMapk-38p/erk Signaling PathwaysAging-associated DiseasePharmacologySynaptic SignalingProtective Mechanisms